Dr. Sujit Itty, MD

NPI: 1699902577
Total Payments
$17,031
2024 Payments
$3,046
Companies
22
Transactions
180
Medicare Patients
23,080
Medicare Billing
$18.7M

Payment Breakdown by Category

Food & Beverage$8,738 (51.3%)
Consulting$7,000 (41.1%)
Travel$1,293 (7.6%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $8,738 172 51.3%
Consulting Fee $7,000 2 41.1%
Travel and Lodging $1,293 6 7.6%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $5,752 20 $0 (2024)
Allergan, Inc. $3,674 20 $0 (2021)
Alimera Sciences, Inc. $3,189 15 $0 (2024)
Genentech USA, Inc. $1,207 30 $0 (2024)
Regeneron Healthcare Solutions, Inc. $818.22 26 $0 (2024)
Novartis Pharmaceuticals Corporation $456.48 17 $0 (2021)
Bausch & Lomb Americas Inc. $308.34 15 $0 (2024)
Biogen, Inc. $299.63 8 $0 (2024)
Astellas Pharma US Inc $284.04 8 $0 (2024)
Dutch Ophthalmic, USA $243.38 2 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $3,046 43 Alimera Sciences, Inc. ($1,990)
2023 $1,735 37 Alimera Sciences, Inc. ($442.67)
2022 $6,842 34 ABBVIE INC. ($5,585)
2021 $425.42 17 Allergan, Inc. ($159.35)
2020 $205.36 6 Novartis Pharmaceuticals Corporation ($145.19)
2019 $561.06 13 Novartis Pharmaceuticals Corporation ($184.15)
2018 $302.44 11 Genentech USA, Inc. ($175.27)
2017 $3,913 19 Allergan Inc. ($3,489)

All Payment Transactions

180 individual payment records from CMS Open Payments — Page 1 of 8

Date Company Product Nature Form Amount Type
12/19/2024 Genentech USA, Inc. Vabysmo (Drug) Food and Beverage In-kind items and services $10.08 General
Category: Immunology and Ophthalmology
12/17/2024 ABBVIE INC. OZURDEX (Drug) Food and Beverage In-kind items and services $24.42 General
Category: EYE CARE
12/06/2024 Bausch & Lomb Americas Inc. XIPERE (Drug) Food and Beverage In-kind items and services $20.92 General
Category: Ophthalmology
11/22/2024 Astellas Pharma US Inc Izervay (Drug) Food and Beverage In-kind items and services $23.45 General
Category: Ophthalmology
11/21/2024 ABBVIE INC. OZURDEX (Drug) Food and Beverage In-kind items and services $18.38 General
Category: EYE CARE
11/07/2024 Genentech USA, Inc. Vabysmo (Drug) Food and Beverage In-kind items and services $34.02 General
Category: Immunology and Ophthalmology
11/07/2024 Bausch & Lomb Americas Inc. XIPERE (Drug) Food and Beverage In-kind items and services $21.70 General
Category: Ophthalmology
11/05/2024 Genentech USA, Inc. Vabysmo (Drug) Food and Beverage In-kind items and services $34.18 General
Category: Immunology and Ophthalmology
10/30/2024 Genentech USA, Inc. Vabysmo (Drug) Food and Beverage In-kind items and services $34.44 General
Category: Immunology and Ophthalmology
10/01/2024 Bausch & Lomb Americas Inc. XIPERE (Drug) Food and Beverage In-kind items and services $22.14 General
Category: Ophthalmology
09/26/2024 Alimera Sciences, Inc. YUTIQ (Drug), ILUVIEN Food and Beverage In-kind items and services $264.51 General
Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye
09/23/2024 Regeneron Healthcare Solutions, Inc. EYLEA HD (Biological) Food and Beverage In-kind items and services $31.69 General
Category: OPHTHALMOLOGY
09/16/2024 Apellis Pharmaceuticals, Inc. Syfovre (Drug) Food and Beverage In-kind items and services $21.26 General
Category: Ophthalmology
09/11/2024 Bausch & Lomb Americas Inc. XIPERE (Drug) Food and Beverage In-kind items and services $22.37 General
Category: Ophthalmology
09/11/2024 Bausch & Lomb Americas Inc. XIPERE (Drug) Food and Beverage In-kind items and services $21.02 General
Category: Ophthalmology
09/11/2024 Bausch & Lomb Americas Inc. XIPERE (Drug) Food and Beverage In-kind items and services $16.03 General
Category: Ophthalmology
09/09/2024 Regeneron Healthcare Solutions, Inc. EYLEA HD (Biological) Food and Beverage In-kind items and services $30.77 General
Category: OPHTHALMOLOGY
09/06/2024 Genentech USA, Inc. Susvimo (Drug) Food and Beverage In-kind items and services $33.69 General
Category: Immunology and Ophthalmology
08/26/2024 Alimera Sciences, Inc. YUTIQ (Drug), ILUVIEN Food and Beverage In-kind items and services $328.74 General
Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye
08/16/2024 Astellas Pharma US Inc Izervay (Drug) Food and Beverage In-kind items and services $23.75 General
Category: Ophthalmology
07/23/2024 Genentech USA, Inc. Vabysmo (Drug) Food and Beverage In-kind items and services $26.44 General
Category: Immunology and Ophthalmology
07/16/2024 Astellas Pharma US Inc Izervay (Drug) Food and Beverage In-kind items and services $29.04 General
Category: Ophthalmology
07/15/2024 Regeneron Healthcare Solutions, Inc. EYLEA HD (Biological) Food and Beverage In-kind items and services $29.72 General
Category: OPHTHALMOLOGY
06/11/2024 Regeneron Healthcare Solutions, Inc. EYLEA HD (Biological) Food and Beverage In-kind items and services $33.47 General
Category: OPHTHALMOLOGY
06/03/2024 Regeneron Healthcare Solutions, Inc. EYLEA HD (Biological) Food and Beverage In-kind items and services $36.52 General
Category: OPHTHALMOLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 27 6,942 101,923 $21.3M $6.2M
2022 26 6,233 28,778 $15.5M $4.5M
2021 23 5,397 20,467 $13.7M $4.2M
2020 21 4,508 17,849 $6.1M $3.8M
Total Patients
23,080
Total Services
169,017
Medicare Billing
$18.7M
Procedure Codes
97

All Medicare Procedures & Services

97 procedure records from CMS Medicare Utilization — Page 1 of 4

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
J2777 Injection, faricimab-svoa, 0.1 mg Office 2023 266 79,680 $7.6M $2.3M 30.5%
J0178 Injection, aflibercept, 1 mg Office 2023 274 2,422 $5.6M $1.7M 29.7%
Q5128 Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg Office 2023 221 3,244 $2.3M $699,262 29.9%
67028 Injection of drug into eye Office 2023 859 3,394 $1.1M $325,893 28.3%
J2778 Injection, ranibizumab, 0.1 mg Office 2023 102 1,270 $1.0M $234,577 22.7%
Q5124 Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg Office 2023 102 985 $738,750 $169,469 22.9%
92134 Imaging of retina Office 2023 1,728 4,727 $496,135 $133,485 26.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 935 1,340 $361,800 $117,293 32.4%
J7312 Injection, dexamethasone, intravitreal implant, 0.1 mg Office 2023 44 693 $346,500 $109,844 31.7%
92014 Established patient complete exam of visual system Office 2023 790 1,067 $336,105 $96,613 28.7%
92012 Established patient problem focused exam of visual system Office 2023 661 1,064 $234,080 $61,198 26.1%
J3490 Unclassified drugs Office 2023 15 37 $296,000 $60,128 20.3%
J7999 Compounded drug, not otherwise classified Office 2023 333 656 $186,960 $47,001 25.1%
67042 Removal of membrane of retina with removal of internal limiting membrane of retina Facility 2023 41 43 $123,410 $37,314 30.2%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 299 299 $122,590 $32,827 26.8%
67113 Complex repair of detached retina and drainage of eye fluid between lens and retina Facility 2023 25 29 $96,715 $27,836 28.8%
J3299 Injection, triamcinolone acetonide (xipere), 1 mg Office 2023 12 720 $82,980 $27,185 32.8%
67039 Destruction of eye fluid (vitreous) between lens and retina using a laser Facility 2023 15 15 $36,000 $10,958 30.4%
92235 Exam of retinal blood vessels using a special camera after injection of a dye Office 2023 63 66 $17,160 $6,563 38.2%
67210 Destruction of growth of retina using a laser Office 2023 11 12 $24,510 $6,106 24.9%
67145 Photocoagulation treatment to prevent detachment of retina Office 2023 28 29 $52,080 $5,528 10.6%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2023 27 27 $14,040 $4,046 28.8%
67228 Destruction of leaking blood vessels of retina using laser Office 2023 11 13 $13,500 $3,174 23.5%
92004 New patient complete exam of visual system Office 2023 31 31 $11,625 $3,087 26.6%
0465T Injection of medication into space above choroid membrane of eye Office 2023 12 18 $4,590 $1,562 34.0%

About Dr. Sujit Itty, MD

Dr. Sujit Itty, MD is a Retina Specialist healthcare provider based in Phoenix, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/17/2009. The National Provider Identifier (NPI) number assigned to this provider is 1699902577.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sujit Itty, MD has received a total of $17,031 in payments from pharmaceutical and medical device companies, with $3,046 received in 2024. These payments were reported across 180 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($8,738).

As a Medicare-enrolled provider, Itty has provided services to 23,080 Medicare beneficiaries, totaling 169,017 services with total Medicare billing of $18.7M. Data is available for 4 years (2020–2023), covering 97 distinct procedure/service records.

Practice Information

  • Specialty Retina Specialist
  • Other Specialties Ophthalmology
  • Location Phoenix, AZ
  • Active Since 06/17/2009
  • Last Updated 01/26/2022
  • Taxonomy Code 207WX0107X
  • Entity Type Individual
  • NPI Number 1699902577

Products in Payments

  • OZURDEX (Drug) $9,334
  • YUTIQ (Drug) $2,237
  • ILUVIEN (Drug) $892.36
  • Vabysmo (Drug) $518.41
  • EYLEA (Biological) $499.07
  • Lucentis (Biological) $457.01
  • EYLEA HD (Biological) $319.15
  • XIPERE (Drug) $308.34
  • BEOVU (Drug) $280.61
  • EVA Ophthalmic Surgical System (Device) $125.00
  • STELLARIS PC (Device) $121.09
  • EVA, combined machine (Device) $118.38
  • Syfovre (Drug) $113.17
  • VABYSMO (Drug) $105.26
  • Izervay (Drug) $104.15
  • ISTENT TRABECULAR MICRO-BYPASS STENT SYSTEM (Device) $85.34
  • Humira (Biological) $77.25
  • XIIDRA (Drug) $74.46
  • Iluvien (Drug) $60.17
  • Bromsite (Drug) $57.70

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Retina Specialist Doctors in Phoenix